Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.6 AUD | -.--% |
|
-5.04% | -.--% |
May. 15 | Medlab Clinical Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Apr. 24 | Medlab Clinical Limited Reports Earnings Results for the Full Year Ended June 30, 2023 | CI |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Research, Development and Pre-commercialisation
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -30.44% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -30.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kerem Kaya
DFI | Director of Finance/CFO | - | 21-05-12 |
Jeremy Henson
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
David A. Rutolo
CTO | Chief Tech/Sci/R&D Officer | - | 15-01-21 |
Laine Yonker
IRC | Investor Relations Contact | - | - |
Tony Potter
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Hudson
BRD | Director/Board Member | - | 23-03-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,283,502 | 1,338,965 ( 58.64 %) | 0 | 58.64 % |
Company contact information
![address Medlab Clinical Limited(MDC)](https://cdn.zonebourse.com/static/address/23021552.png)
Sector
Sales per Business
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 10.24M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- MDC Stock
- Company Medlab Clinical Limited